Sofosbuvir based treatment of chronic hepatitis C genotype 3 infections—A Scandinavian real-life study-Reference-Cited by-同舟云学术

Sofosbuvir based treatment of chronic hepatitis C genotype 3 infections—A Scandinavian real-life study

Published:2017-07-13 Issue:7 Volume:12 Page:e0179764
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Dalgard Olav^ORCID,Weiland Ola,Noraberg Geir,Karlsen Lars,Heggelund Lars,Färkkilâ Martti,Balslev Ulla,Belard Erika,Øvrehus Anne,Skalshøi Kjær Mette,Krarup Henrik,Thorup Røge Birgit,Hallager Sofie,Madsen Lone G.,Lund Laursen Alex,Lagging Martin,Weis Nina

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference24 articles.

1. A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel;M Cornberg;Liver Int,2011

2. Historical epidemiology of hepatitis C virus (HCV) in selected countries;P Bruggmann;J Viral Hepat,2014

3. HCV genotype 3 is associated with an increased risk of cirrhosis and hepatocellular cancer in a national sample of U.S. Veterans with HCV;F Kanwal;Hepatology,2014

4. Boceprevir for untreated chronic HCV genotype 1 infection;F Poordad;N Engl J Med

5. Boceprevir for untreated chronic HCV genotype 1 infection;F Poordad;N Engl J Med,2011

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiparametric liver assessment in patients successfully treated for hepatitis C: a 4-year follow-up;Scandinavian Journal of Gastroenterology;2024-09

2. Efficacy, safety, and quality of life profile of Genotype-3 Chronic Hepatitis-C Pakistani patients receiving ledipasvir plus sofosbuvir treatment;Pakistan Journal of Medical Sciences;2024-06-22

3. EFETIVIDADE DE ANTIVIRAIS DE AÇÃO DIRETA NO TRATAMENTO DA COINFECÇÃO VÍRUS DA HEPATITE C E VÍRUS DA IMUNODEFICIÊNCIA HUMANA;Cadernos ESP;2023-12-26

4. Recurrence of hepatitis C virus after treatment with pegylated interferon and direct acting antivirals in Punjab Pakistan;Brazilian Journal of Biology;2023

5. Selection dynamics of HCV genotype 3 resistance-associated substitutions under direct-acting antiviral therapy pressure;The Brazilian Journal of Infectious Diseases;2022-11